Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

For people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to ...

The t:slim X2 insulin pump with Control-IQ technology is the #1-rated automated insulin delivery (AID) system1, and now the first and only insulin pump in Canada t Tandem Diabetes Care (TNDM ...

In recent filings with the Securities and Exchange Commission, Embecta Corp. (NASDAQ:EMBC) Director Morris Milton Mayo reported a series of transactions involving the company's common stock. On ...

Embecta Corp. (NASDAQ:EMBC) announced that its Annual Meeting of Stockholders, which took place on Monday, resulted in the ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...